Skip to main content
Clinical Trials/NCT02776553
NCT02776553
Completed
Not Applicable

A Physical Activity Program in End-stage Liver Disease: Pilot Study Assessing Changes in Physical Fitness, Sarcopenia, and the Metabolic Profile

University of Arkansas1 site in 1 country20 target enrollmentJune 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
End-stage Liver Disease (ESLD)
Sponsor
University of Arkansas
Enrollment
20
Locations
1
Primary Endpoint
Sarcopenia
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The primary aim of this study is to improve both physical fitness and sarcopenia of patients with ESLD who are potentially eligible for liver transplantation through a 12-week physical training program. Secondary aims will focus on changes in anthropometrics, body composition, quality of life, and metabolic profile. This is a randomized clinical trial including 50 patients, with half allocated to the active group (physical training program) and half to standard of care.

Registry
clinicaltrials.gov
Start Date
June 2016
End Date
June 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 40 to
  • Cirrhosis, any cause, defined as:
  • Biopsy-proven.
  • Two or more of the following: albumin \<3.5 g/dL, International Normalized Ration (INR) \>1.3, radiologic or endoscopic evidence of portal hypertension.
  • Creatinine \<2.0 mg/dL.
  • Physiologic Model for End Stage Liver Disease (MELD) ≥
  • Decompensated cirrhosis with active or history of variceal bleeding, ascites, hepatic encephalopathy, or jaundice.
  • Potential transplant candidate as per UAMS criteria

Exclusion Criteria

  • Large gastric or esophageal varices with contraindication to use beta-blockers.
  • Persistent hepatic encephalopathy grades 2-
  • Prior diagnosis of hepatocellular carcinoma, or hepatic hydrothorax (with prior repeated thoracocentesis).
  • Cirrhotic cardiomyopathy or congestive heart failure, pulmonary vascular complications, known active coronary artery disease, syncope, and cardiac dysrhythmias.
  • Physical impediment to perform a cardiorespiratory fitness test.
  • Use of implantable defibrillator or a pacemaker.

Outcomes

Primary Outcomes

Sarcopenia

Time Frame: Change from Baseline to 12 weeks after baseline

Total thigh muscle volume (cm\^3), as determined by CT-scan.

Physical Fitness - Distance Walked

Time Frame: Change from Baseline to 12 weeks after baseline

Total distance walked during 6-minute walk test

Physical Fitness - VO2

Time Frame: Change from Baseline to 12 weeks after baseline

Peak VO2 will be obtained from cardiorespiratory stress test

Study Sites (1)

Loading locations...

Similar Trials